CRIS Current Research Information System

SABATTINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.329
AS - Asia 7.302
EU - Europa 5.138
AF - Africa 455
SA - Sud America 399
Continente sconosciuto - Info sul continente non disponibili 378
OC - Oceania 13
Totale 22.014
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.168
VN - Vietnam 2.026
SG - Singapore 1.935
CN - Cina 1.880
GB - Regno Unito 1.240
IT - Italia 740
SE - Svezia 695
DE - Germania 685
HK - Hong Kong 461
FR - Francia 361
IN - India 338
UA - Ucraina 309
BR - Brasile 274
RU - Federazione Russa 267
IE - Irlanda 191
KR - Corea 152
NL - Olanda 140
ZA - Sudafrica 131
JP - Giappone 121
FI - Finlandia 113
CI - Costa d'Avorio 110
TG - Togo 92
CA - Canada 84
BD - Bangladesh 68
EE - Estonia 67
CH - Svizzera 66
AR - Argentina 47
JO - Giordania 47
BG - Bulgaria 43
NG - Nigeria 39
BE - Belgio 38
PH - Filippine 37
MX - Messico 35
ID - Indonesia 34
SC - Seychelles 33
TH - Thailandia 32
IR - Iran 26
LU - Lussemburgo 25
EC - Ecuador 24
TR - Turchia 24
PL - Polonia 23
AT - Austria 22
TW - Taiwan 22
ES - Italia 20
HR - Croazia 20
IQ - Iraq 17
GR - Grecia 16
CO - Colombia 15
SA - Arabia Saudita 15
PK - Pakistan 14
JM - Giamaica 12
LT - Lituania 12
RO - Romania 12
AU - Australia 11
UZ - Uzbekistan 11
CL - Cile 10
EG - Egitto 9
LB - Libano 8
PE - Perù 8
PY - Paraguay 8
KE - Kenya 7
DZ - Algeria 6
GT - Guatemala 6
DK - Danimarca 5
MA - Marocco 5
UY - Uruguay 5
AL - Albania 4
CZ - Repubblica Ceca 4
GH - Ghana 4
KG - Kirghizistan 4
PA - Panama 4
PT - Portogallo 4
TN - Tunisia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
KH - Cambogia 3
LV - Lettonia 3
MY - Malesia 3
PS - Palestinian Territory 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HU - Ungheria 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
UG - Uganda 2
Totale 21.614
Salva come PNG Salva come JPEG
Città #
Singapore 1.350
Southend 1.042
Ashburn 885
Fairfield 764
San Jose 527
Chandler 476
Hong Kong 431
Dong Ket 394
Hanoi 362
Ho Chi Minh City 357
Hefei 340
Houston 338
Woodbridge 334
Seattle 332
Wilmington 327
Cambridge 285
Ann Arbor 273
Princeton 270
Beijing 242
Santa Clara 220
Dublin 190
Boardman 187
Jacksonville 180
Council Bluffs 165
Lauterbourg 136
Seoul 134
Los Angeles 124
New York 124
Nanjing 121
Abidjan 110
Tokyo 106
Westminster 106
Bologna 97
Lomé 92
Padova 89
Helsinki 84
Bremen 78
Berlin 77
Dallas 72
Buffalo 70
Milan 69
London 66
Haiphong 63
Jinan 61
Da Nang 60
Bern 56
Saint Petersburg 51
Frankfurt am Main 50
Shenyang 48
Amman 47
San Diego 46
Hebei 44
Mülheim 44
São Paulo 44
Nanchang 42
Sofia 42
Chicago 41
Munich 40
Redondo Beach 40
Changsha 38
Shanghai 38
Tianjin 38
Brussels 37
Guangzhou 36
Phoenix 36
Abeokuta 35
Bengaluru 32
Johannesburg 31
Hyderabad 29
Hangzhou 28
Rome 28
Zhengzhou 27
Medford 26
Redwood City 26
Turin 26
Redmond 24
Jiaxing 23
Toronto 22
Des Moines 21
Hải Dương 21
Orem 21
Lappeenranta 20
San Venanzo 20
The Dalles 20
Falkenstein 19
Olalla 19
Taizhou 19
Yubileyny 19
Haikou 18
Norwalk 18
Brooklyn 17
Florence 17
Thái Nguyên 17
Warsaw 17
Can Tho 16
Dearborn 16
Mahé 16
Montreal 16
Chennai 15
Quận Bình Thạnh 15
Totale 13.822
Salva come PNG Salva come JPEG
Nome #
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 306
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens 289
Biology and treatment of follicular lymphoma. 285
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 281
Comparison of JAK2V617F-positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology 279
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 276
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 260
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 254
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 247
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 243
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 238
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 230
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 217
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 217
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 210
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 210
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 210
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 207
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 204
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 203
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 200
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 198
CD30 expression in peripheral T-cell lymphomas 197
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 196
Histopathology of B-cell chronic lymphocytic leukemia. 193
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 192
Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact 191
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 189
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 187
A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy. 187
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 187
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 187
Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience 186
Pathobiology of hodgkin lymphoma. 184
Anaplastic Large Cell Lymphoma: a critical reappraisal 182
Unusual inflammatory and hyperkeratotic halo naevus in children. 181
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 181
BCL10 down-regulation in peripheral T-cell lymphomas. 181
First Italian birth after cryopreserved ovarian tissue transplantation in a patient affected by non-Hodgkin's lymphoma 181
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 180
Small bowel obstruction caused by a large B-cell lymphoma in a patient with multicentric Castleman’s disease: an unusual occurrence 180
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 180
CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation. 179
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 177
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 176
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 175
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 174
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 173
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 172
Pathobiology of anaplastic large cell lymphoma. 171
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 170
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 166
Granulomatous tattoo reaction in a nivolumab-treated patient 166
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. 165
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis 164
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 162
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. 162
Pathobiology of ALK-negative anaplastic large cell lymphoma. 161
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 159
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 158
Simple diagnostic assay for hairy cell leukemia by cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 157
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 157
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease. 156
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. 155
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 155
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma 155
Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment 154
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 153
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. 151
Primary cutaneous lymphomas: a reprisal 151
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 151
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET 150
Prognostic markers in peripheral T-cell lymphoma. 147
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 147
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 147
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 147
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in 5 cases. 145
Genetic and phenotypic attributes of splenic marginal zone lymphoma 144
Pathobiology of acute lymphoblastic leukemia. 144
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 144
SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients, methodological issue on reproducibility and validity—reply 144
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 144
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 144
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 143
Brownish asymptomatic lesions on the arms and legs 143
Multiple intra-axial lesions in a 57-year-old male with a history of B-cell chronic lymphocytic leukemia 143
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 142
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays. 140
Lymphoplasmacytic lymphoma and marginal zone lymphoma: diagnostic challenges 139
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210 137
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 137
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 136
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 135
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 135
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model 134
Safety of cryopreserved ovarian tissue autotransplantation in leukaemia patients 134
Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience 133
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 133
PET/CT guided biopsy in lymphoma patients 132
Bone marrow in Hodgkin lymphoma and mimickers. 130
Totale 17.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.998 0 93 135 179 239 106 43 151 82 172 468 330
2022/20232.483 295 390 145 311 177 186 72 125 409 65 188 120
2023/2024713 37 120 62 56 64 159 45 52 23 52 13 30
2024/20252.918 136 447 283 209 391 142 243 96 44 197 161 569
2025/20267.166 624 675 622 612 809 367 706 262 1.404 549 265 271
2026/2027482 189 293 0 0 0 0 0 0 0 0 0 0
Totale 22.014